Cargando…

The Utility of Pharmacogenetic-Guided Psychotropic Medication Selection for Pediatric Patients: A Retrospective Study

Background: To describe trends and clinical experiences in applying commercial pharmacogenetic testing among pediatric patients with neuropsychiatric disorders. Methods: Demographic and clinical data of patients receiving GeneSight(®) testing from January 2015 to November 2016 at an urban pediatric...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ariefdjohan, Merlin, Lee, Yee Ming, Stutzman, Danielle L., LeNoue, Sean, Wamboldt, Marianne Z.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8396342/ https://www.ncbi.nlm.nih.gov/pubmed/34449718 http://dx.doi.org/10.3390/pediatric13030049

Ejemplares similares

Positive perception of pharmacogenetic testing for psychotropic medications
por: Lanktree, Matthew B, et al.
Publicado: (2014)

Variability Between Clinical Pharmacogenetics Implementation Consortium (CPIC(®)) Guidelines and a Commercial Pharmacogenetics Laboratory in Genotype to Phenotype Interpretations For Patients Utilizing Psychotropics
por: Blazy, Christopher, et al.
Publicado: (2022)

Cases of Adverse Reaction to Psychotropic Drugs and Possible Association with Pharmacogenetics
por: Piatkov, Irina, et al.
Publicado: (2012)

Pharmacogenetic Guidelines for Psychotropic Drugs: Optimizing Prescriptions in Clinical Practice
por: Baldacci, Antoine, et al.
Publicado: (2023)

Utilization of psychotropic medications in children with FASD: a retrospective review
por: Durr, Michael-Roy R., et al.
Publicado: (2021)

Pharmacogenetics May Prevent Psychotropic Adverse Events in Autism Spectrum Disorder: An Observational Pilot Study
por: de Miguel, Laura, et al.
Publicado: (2023)

Long-term use of antidepressants, mood stabilizers, and antipsychotics in pediatric patients with a focus on appropriate deprescribing
por: Stutzman, Danielle L.
Publicado: (2021)

The Potential Utility of Pharmacogenetic Testing in Psychiatry
por: Gardner, Kathryn R., et al.
Publicado: (2014)

The Utility of Pharmacogenetics Testing in Psychiatric Populations
por: Jürgens, Gesche
Publicado: (2021)

Psychotropic Drug Utilization Pattern among Schizophrenics
por: Dutta, Shakti Bala, et al.
Publicado: (2004)

Pharmacogenetics of Pediatric Asthma: Current Perspectives
por: Perez-Garcia, Javier, et al.
Publicado: (2020)

Psychotropic drug utilization pattern among patients with schizophrenia
por: Dutta, Shakti Bala, et al.
Publicado: (2005)

Utilization of psychotropic medicines in Romania during 1998–2018
por: Iaru, Irina, et al.
Publicado: (2023)

Pharmacogenetics and Psychiatric Care: A Review and Commentary
por: Butler, Merlin G.
Publicado: (2018)

Comparison of DNA extraction kits for PCR-DGGE analysis of human intestinal microbial communities from fecal specimens
por: Ariefdjohan, Merlin W, et al.
Publicado: (2010)

Trends in the utilization of psychotropic medications in China from 2018 to 2021
por: Zhang, Xinyan, et al.
Publicado: (2022)

S222. CLINICAL UTILITY OF PHARMACOGENETIC TESTING IN SCHIZOPHRENIA TREATMENT
por: Mueller, Daniel, et al.
Publicado: (2018)

The utility of pharmacogenetic testing to support the treatment of bipolar disorder
por: Ielmini, Marta, et al.
Publicado: (2018)

Utilizing pharmacogenetics when treating first episode psychosis
por: Korchia, Theo, et al.
Publicado: (2023)

Pharmacogenetically Guided Escitalopram Treatment for Pediatric Anxiety Disorders: Protocol for a Double-Blind Randomized Trial
por: Strawn, Jeffrey R., et al.
Publicado: (2021)

Pharmacogenomic Profiling of Pediatric Patients on Psychotropic Medications in an Emergency Department
por: Ghosh, Pallavi, et al.
Publicado: (2023)

Pharmacogenetic-Guided Antidepressant Selection as an Opportunity for Interprofessional Collaboration: A Case Report
por: Stäuble, Céline K., et al.
Publicado: (2021)

Perspectives from the Society for Pediatric Research: Pharmacogenetics for Pediatricians
por: Tang Girdwood, Sonya C., et al.
Publicado: (2022)

Cost-effectiveness of pharmacogenetic-guided treatment: are we there yet?
por: Verbelen, M, et al.
Publicado: (2017)

Pulse Oximetry Values in Newborns with Critical Congenital Heart Disease upon ICU Admission at Altitude
por: Kim, John S., et al.
Publicado: (2018)

Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer
por: Bernard, Philip S., et al.
Publicado: (2021)

Psychotropic drugs
por: Keltner, Norman L.
Publicado: (1993)

Glaucoma and Psychotropics
por: Cavaco, T., et al.
Publicado: (2022)

Utility of pharmacogenetic testing to optimise antidepressant pharmacotherapy in youth: a narrative literature review
por: Roberts, Bradley, et al.
Publicado: (2023)

Developmental Pharmacogenetics in Pediatric Rheumatology: Utilizing a New Paradigm to Effectively Treat Patients with Juvenile Idiopathic Arthritis with Methotrexate
por: Becker, Mara L., et al.
Publicado: (2010)

Association between psychotropic prescriptions and the total amount of psychotropics ingested during an intentional overdose: A single‐center retrospective study
por: Tanahashi, Iori, et al.
Publicado: (2022)

My Cancer Genome: Coevolution of Precision Oncology and a Molecular Oncology Knowledgebase
por: Holt, Marilyn E., et al.
Publicado: (2021)

Effects of pharmacogenetic profiles on pediatric pain relief and adverse events with ibuprofen and oxycodone
por: Ali, Samina, et al.
Publicado: (2023)

Psychotropic Polypharmacy in the US Pediatric Population: A Methodologic Critique and Commentary
por: Zito, Julie M., et al.
Publicado: (2021)

Psychotropic medication use in pediatric population during COVID‐19 pandemic
por: Kuitunen, Ilari
Publicado: (2022)

Retrospective Review of Pharmacogenetic Testing at an Academic Children’s Hospital
por: Roberts, Timothy A., et al.
Publicado: (2020)

Genome sequencing as a platform for pharmacogenetic genotyping: a pediatric cohort study
por: Cohn, Iris, et al.
Publicado: (2017)

The limited utility of electrocardiography variables used to predict arrhythmia in psychotropic drug overdose
por: Buckley, Nicholas A, et al.
Publicado: (2003)

Drug Utilization Study of Psychotropic Drugs in Outdoor Patients in a Teaching Hospital
por: Piparva, K. G., et al.
Publicado: (2011)

Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia
por: Wu, Angela, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_09bqn8f9ltc1q6mnk6rpqbk87m